Evolus GAAP EPS of -$0.27 misses by $0.07, revenue of $69.4M misses by $12.64M
Source: SeekingAlpha
2025-08-05 16:09:02 ET
More on Evolus
- Evolus - A Slightly Risky Buy Ahead Of Q2 Earnings
- Evolus, Inc. (EOLS) Q1 2025 Earnings Call Transcript
- Evolus projects $345M-$355M revenue for 2025 with new product launches
- Seeking Alpha’s Quant Rating on Evolus
- Historical earnings data for Evolus
Read the full article on Seeking Alpha
For further details see:
Evolus GAAP EPS of -$0.27 misses by $0.07, revenue of $69.4M misses by $12.64M
Evolus Inc.
NASDAQ: EOLS
EOLS Trading
-6.91% G/L:
$4.85 Last:
301,893 Volume:
$4.96 Open:
EOLS Latest News
EOLS Stock Data
$288,448,039
43,258,131
1.1%
49
N/A
Pharmaceuticals
Healthcare
US
Newport Beach
